Peptide Series
Focused exclusively on DMPK-driven peptide drug development, this series dives deep into critical pharmacokinetic challenges: optimizing absorption/metabolic stability, mitigating renal clearance, and refining bioanalytical workflows. Continuously updated, the series equips teams with actionable, phase-agnostic solutions to accelerate therapeutic candidates from discovery to clinical success while navigating regulatory complexities.
-
Novel Drug Modalities
-
Therapeutic Areas
Connect with us
-
Insights into Chiral Drug Metabolism and Inversion
ArticlesFeb 13,2025Learn More
-
Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
PostersFeb 13,2025Learn More -
Antibody-Drug Conjugate (ADC) Preclinical PK/PD Study Strategies and Practices
ArticlesFeb 19,2025Learn More -
Introduction to Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and Its Applications in Bioanalysis
ArticlesFeb 26,2025Learn More -
Review on the bioanalysis of non-virus-based gene therapeutics
PublicationMar 07,2025Learn More -
Developing a Convenient In Vitro Method for Predicting Metabolism and Disposition of Acrylamide Covalent Drugs in Humans
White PapersMar 07,2025Learn More
Load More
View More
Still have a question?
Talk to an expert
Related Service
Stay Connected
Keep up with the latest news and insights.
